Osama A. Samargandi

Osama A. Samargandi

Auto-generated profile, based on publicly available information

Osama A. Samargandi

Division of Plastic Surgery, Department of Surgery, King Abdulaziz University, Jeddah, Saudi Arabia.

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2019 in JAMA Facial Plastic Surgery
Verified
Journal Article
Closed access
PDF file
CMConnor McGuire
Connor McGuire
SNSean Nurmsoo
Sean Nurmsoo
OSOsama A. Samargandi
Osama A. Samargandi
MBMichael Bezuhly
Michael Bezuhly
Importance Blood loss from surgical procedures is a major issue worldwide as the demand for blood products is increasing. Tranexamic acid is an antifibrinolytic agent commonly used to reduce intraoperative blood loss. Objective To systematically examine the role of tranexamic acid in reducing intraoperative blood loss and postoperative edema and ecchymosis among patients undergoing primary elective rhinoplasty. Data Sources A systematic review and meta-analysis was undertaken in an academic medical setting using Medline, Embase, and Google Scholar from inception to June 30, 2018. All references of included articles were screened for potential inclusion. The search was mapped to Medical Subject Headings, and the following terms were used to identify potential articles:reconstructionorrhinoplastyandtranexamic acidoranti-fibrinolysisorantifibrinolysisandbleedingorecchymosisorbruisingoredemaorcomplications. Study Selection The population of interest consisted of adult patients undergoing primary elective rhinoplasty. The intervention was the use of tranexamic acid. The control group was composed of patients receiving a placebo. Primary outcomes were intraoperative blood loss and postoperative edema and ecchymosis. In vitro or animal studies were excluded, and only English-language articles were included. Data Extraction and Synthesis The PRISMA guidelines were followed, and articles were assessed using the Cochrane Collaboration’s tool for assessing risk of bias and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) guidelines. Random-effects meta-analysis was performed to determine the overall effect size. Main Outcomes and Measures The primary outcomes were intraoperative blood loss and postoperative edema and ecchymosis. Results Five studies (comprising 332 patients) were included in the qualitative analysis, all of which were randomized clinical trials published within the past 5 years. The mean (SD) patient age was 27 (7) years (age range, 16-42 years), while the mean (SD) sample size was 66 (19) (range, 50-96). Meta-analysis of 4 studies (271 patients) indicated that tranexamic acid treatment resulted in a mean reduction in intraoperative blood loss of −41.6 mL (95% CI, −69.8 to −13.4 mL) compared with controls (P = .004). Three studies indicated that postoperative edema and ecchymosis were reduced with tranexamic acid treatment compared with controls; however, there was no significant difference compared with corticosteroid use. Four studies were considered of high methodological quality, with a low risk of bias. The overall quality of evidence was high. Conclusions and Relevance Tranexamic acid has the ability to significantly reduce intraoperative blood loss and postoperative edema and ecchymosis among patients undergoing primary elective rhinoplasty. Level of Evidence 4.

18 December 2018 in Annals of Plastic Surgery
Verified
Journal Article
Closed access
KBKaitlin S. Boehm
Kaitlin S. Boehm
MAMona Al-Taha
Mona Al-Taha
AMAlexander Morzycki
Alexander Morzycki
OSOsama A. Samargandi
Osama A. Samargandi
SASarah Al-Youha
Sarah Al-Youha
MLMartin R. LeBlanc
Martin R. LeBlanc
Background: The iliac crest bone graft (ICBG) is criticized for high donor site morbidity. Recent research suggests this morbidity is related to the patient population for which the ICBG is harvested. This systematic review is the first to delineate the type and incidence of ICBG donor site complications in craniofacial surgery. Methods: Two independent reviewers conducted a systematic review of multiple databases (MEDLINE, EMBASE, CINAHL, PEDRO, and Cochrane Central Register of Controlled Trials) from 1917 to 2017. All studies utilizing the ICBG for craniofacial indications were included. Donor site morbidities, including immediate and chronic pain, hematoma, seroma, infection, hypertrophic/painful scarring, nerve injury, muscle herniation, iliac crest fracture, and gait disturbance, were recorded. A weighted incidence for each morbidity, excluding immediate pain, was calculated. An average visual analog scale score was calculated for immediate pain. Results: Forty-four studies, with 2801 patients, were included. Oral and maxillofacial (50%) and cleft reconstruction (40%) were the primary indications for surgery. Average immediate pain visual analog scale scores on postoperative days 1 and 14 were 6.3 and 1.3, respectively. The incidence of donor site morbidities was as follows: acute (45.7%) and chronic (1.5%) gait disturbance, acute (17.8%) and chronic nerve changes (1.4%), hypertrophic/painful scar (9.1%), chronic pain (3.1%), hematoma (2.2%), seroma (2.0%), infection (1.0%), iliac crest fracture (1.2%), and muscle herniation (0%). Conclusions: Chronic morbidity was lower than previously documented. Rare chronic morbidity illustrates that the ICBG remains a viable surgical option. The authors hope this review will facilitate surgical planning and informed consent.

23 October 2020 in Aesthetic Plastic Surgery
Verified
Journal Article
Closed access
PDF file
RERawan ElAbd
Rawan ElAbd
OSOsama A. Samargandi
Osama A. Samargandi
KAKhalifa AlGhanim
Khalifa AlGhanim
SASalma Alhamad
Salma Alhamad
SASulaiman Almazeedi
Sulaiman Almazeedi
SASarah AlYouha
Sarah AlYouha

1 November 2017 in Journal of Surgical Education
Verified
Journal Article
Closed access
MAMona Al-Taha
Mona Al-Taha
SYSarah Al Youha
Sarah Al Youha
BABecher Al-Halabi
Becher Al-Halabi
JSJill Stone
Jill Stone
HRHelene Retrouvey
Helene Retrouvey
JWJason G. Williams
Jason G. Williams

1 January 2012 in North American Journal of Medical Sciences
Verified
Journal Article
Open access
PDF file
SASaleh M Aldaqal
Saleh M Aldaqal
BEBasem S El-Deek
Basem S El-Deek
AAAbdulrahmanA Ashy
AbdulrahmanA Ashy
OSOsamaA Samargandi
OsamaA Samargandi
BABasimA Awan
BasimA Awan
AKAhmedA Kensarah
AhmedA Kensarah
Background: Morbid obesity has become a common problem worldwide and as a result the demand for bariatric surgery has increased as well. Most patients develop skin redundancy and sagging at many body parts after major weight loss procedures which increased the demand for body contouring procedures. Aims : The study was to address the prevalence and patient's desire for body contouring procedures. Materials and Methods: A cross-sectional study targeting the postbariatric patients from April 2011 to October 2011 was conducted at our hospital. Questionnaire was administered in order to measure frequency and patients desire to undergo body contouring surgery after massive weight loss. Results: The total number of patients was 128 patients. The mean age of our patients was 37-year old (range 18-56 year). The percentage of the desire for body contouring surgery after bariatric surgery was 78.1%. There was very pronounced desire to body contouring surgery after those who underwent gastric bypass surgery with P-value 0.001. Only 18 patients (14%) have underwent body contouring surgery, with a total of 29 procedures, in which abdominoplasty considered the most commonly procedure performed (57%). Conclusion : With the increasing number of weight loss surgery, there is higher number of patients that desire a body contouring surgery, which create huge disparity between demand and accessibility.

1 January 2013 in North American Journal of Medical Sciences
Verified
Journal Article
Open access
PDF file
SASaleh M Aldaqal
Saleh M Aldaqal
AMAhmad M Makhdoum
Ahmad M Makhdoum
ATAli M Turki
Ali M Turki
BABasimA Awan
BasimA Awan
OSOsamaA Samargandi
OsamaA Samargandi
HJHytham Jamjom
Hytham Jamjom
Background: Following a bariatric surgery and massive weight-loss, the outcome is usually sullied by consequences on the body's contour and redundant skin. Aims: We aimed to record the frequency of contour irregularities and quantify patients' satisfaction with appearance and anticipations from body contouring surgery. Materials and Methods: The ethical committee at King Abdulaziz University Hospital approved the study, and patients were consented. A cross-sectional study targeting the post-bariatric patients from May 2011 to April 2012 was conducted at our hospital. We used post-massive weight loss Satisfaction Questionnaire. Results: The total numbers of patients were 64 (51 women and 13 men), of which 57 patients (89.2%) developed sagging skin. Most patients were dissatisfied with their appearance after weight loss. The most common zones were the upper arms (50%) and abdomen (45%). Considerably more women (36.2%) than men (24%) were dissatisfied with certain body areas. The most noticeable expectation of patients from body contouring surgery was improved cosmetic appearance (65.6%) and self-confidence (64.1%). More women (70.58%) than men (46.15%) expected a better cosmetic appearance after body contouring (P = 0.003). Conclusion: After bariatric surgery, sagging excess skin is an unsatisfactory problem. Therefore, body contouring surgery must be included in morbid obesity management.